Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W C Beasley

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Virology|May 31, 2002
Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotypeDavid W C Beasley, Li Li, Miguel T Suderman, et al.
Brain, Behavior, & Immunity - Health|September 30, 2021
Long-term, West Nile virus-induced neurological changes: A comparison of patients and rodent modelsCorey D M Fulton, David W C Beasley, Dennis A Bente, et al.
Virology|December 14, 2011
Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypesTrevor J Pitcher, Gregory D Gromowski, David W C Beasley, et al.
The Journal of Biological Chemistry|November 8, 2007
Long range communication in the envelope protein domain III and its effect on the resistance of West Nile virus to antibody-mediated neutralizationRodrigo A Maillard, Matthew Jordan, David W C Beasley, et al.
Journal of Clinical Microbiology|November 6, 2004
Characterization of a West Nile virus isolate from a human on the Gulf Coast of TexasBruno P Granwehr, Li Li, Charles T Davis, et al.
Journal of Virology|February 14, 2003
Origin and evolution of Japanese encephalitis virus in southeast AsiaTom Solomon, Haolin Ni, David W C Beasley, et al.
The Journal of Infectious Diseases|June 17, 2009
Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virusShuliu Zhang, Matthew R Vogt, Theodore Oliphant, et al.
Virology|May 2, 2006
Structure of the envelope protein domain III of Omsk hemorrhagic fever virusDavid E Volk, Leonard Chavez, David W C Beasley, et al.
Journal of the American Chemical Society|June 21, 2014
Thermodynamic mechanism for the evasion of antibody neutralization in flavivirusesRodrigo A Maillard, Tong Liu, David W C Beasley, et al.
Journal of Virology|February 26, 2016
Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse VirulenceAlexander J McAuley, Maricela Torres, Jessica A Plante, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Virology|May 31, 2002
Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotypeDavid W C Beasley, Li Li, Miguel T Suderman, et al.
Brain, Behavior, & Immunity - Health|September 30, 2021
Long-term, West Nile virus-induced neurological changes: A comparison of patients and rodent modelsCorey D M Fulton, David W C Beasley, Dennis A Bente, et al.
Virology|December 14, 2011
Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypesTrevor J Pitcher, Gregory D Gromowski, David W C Beasley, et al.
The Journal of Biological Chemistry|November 8, 2007
Long range communication in the envelope protein domain III and its effect on the resistance of West Nile virus to antibody-mediated neutralizationRodrigo A Maillard, Matthew Jordan, David W C Beasley, et al.
Journal of Clinical Microbiology|November 6, 2004
Characterization of a West Nile virus isolate from a human on the Gulf Coast of TexasBruno P Granwehr, Li Li, Charles T Davis, et al.
Journal of Virology|February 14, 2003
Origin and evolution of Japanese encephalitis virus in southeast AsiaTom Solomon, Haolin Ni, David W C Beasley, et al.
The Journal of Infectious Diseases|June 17, 2009
Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virusShuliu Zhang, Matthew R Vogt, Theodore Oliphant, et al.
Virology|May 2, 2006
Structure of the envelope protein domain III of Omsk hemorrhagic fever virusDavid E Volk, Leonard Chavez, David W C Beasley, et al.
Journal of the American Chemical Society|June 21, 2014
Thermodynamic mechanism for the evasion of antibody neutralization in flavivirusesRodrigo A Maillard, Tong Liu, David W C Beasley, et al.
Journal of Virology|February 26, 2016
Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse VirulenceAlexander J McAuley, Maricela Torres, Jessica A Plante, et al.
Pageof 9